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Phosphoinositide 3-kinase p110d promotes lumen
formation through the enhancement of apico-basal
polarity and basal membrane organization
Juan Peng1,2,*, Aline Awad1,2,*, Sokhavuth Sar1,2, Ola Hamze Komaiha1,2, Romina Moyano1,2, Amel Rayal1,2,
Didier Samuel1,2,3, Annette Shewan4, Bart Vanhaesebroeck5, Keith Mostov6 & Ama Gassama-Diagne1,2
Signalling triggered by adhesion to the extracellular matrix plays a key role in the spatial
orientation of epithelial polarity and formation of lumens in glandular tissues. Phosphoino-
sitide 3-kinase signalling in particular is known to inﬂuence the polarization process during
epithelial cell morphogenesis. Here, using Madin–Darby canine kidney epithelial cells grown
in 3D culture, we show that the p110d isoform of phosphoinositide 3-kinase co-localizes with
focal adhesion proteins at the basal surface of polarized cells. Pharmacological, siRNA- or
kinase-dead-mediated inhibition of p110d impair the early stages of lumen formation,
resulting in inverted polarized cysts, with no laminin or type IV collagen assembly at
cell/extracellular matrix contacts. p110d also regulates the organization of focal adhesions
and membrane localization of dystroglycan. Thus, we uncover a previously unrecognized role
for p110d in epithelial cells in the orientation of the apico-basal axis and lumen formation.
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A
pical-basal polarity is a fundamental feature of epithelial
cells required for the structural and functional integrity
of the epithelial tissue1,2. Conversely, the disruption of
polarity in epithelial cells is often associated with infectious
diseases and cancer3. Apical-basal polarity is initiated by
signalling from cell–cell and cell-to-extracellular matrix (ECM)
contacts4,5. Events such as intracellular trafﬁcking6, cytoskeletal
organization7 and actions of evolutionary conserved complexes
mediate further development of the apical and basolateral
membrane domains8. Several recent reports have demonstrated
that mechanical factors are also important regulators of cell
polarity9,10. Establishment of polarity in epithelial cells results in
the segregation of plasma membrane in an apical domain
facing the outside surface of the body, or the lumen of internal
cavities, and the basolateral domain oriented away from the
lumen11.
The phosphoinositide 3-kinase (PI3K) family of lipid kinases is
divided into three different classes based on primary structure,
regulation and lipid substrate speciﬁcity. The class I PI3Ks are the
best characterized and are frequently deregulated in cancer12.
Mammals have four Class I PI3K isoforms, all of which are
heterodimeric PI3K enzymes consisting of a regulatory subunit in
complex with a 110-kDa catalytic subunit, either p110a (PI3Ka),
b (PI3Kb), g (PI3Kg) or d (PI3Kd). p110a and p110b are
ubiquitously expressed, whereas p110g and p110d are enriched in
cells of haematopoietic lineage13. All class I PI3Ks produce the
phosphatidylinositol(3,4,5)-triphosphate (PtdIns(3,4,5)P3) lipid
that controls a complex cellular signalling network, with crucial
roles in regulation of apico-basal polarity and epithelial cell
morphogenesis14–18. PtdIns(3,4,5)P3 signals can be terminated
through the action of the 3-phosphatase PTEN or the 5-
phosphatases SHIP1/2 to produce PtdIns(4,5)P2 and
PtdIns(3,4)P2, respectively19,20. In polarized epithelial cells,
PtdIns(3,4,5)P3 and PI3Ks are mainly present on the basolateral
membrane21, while PTEN plays a central role in the formation
of the apical membrane22. We have recently reported that
SHIP2 is present at the basolateral membrane and regulates cell
polarization23.
Although the involvement of PtdIns(3,4,5)P3 has previously
been established in the polarization of epithelial cells, the
underlying mechanisms and the function of the speciﬁc PI3K
isoforms in this process have not yet been addressed. Here
we demonstrate the presence of p110d at the basolateral
membrane of polarized MDCK cysts. Our data also reveal that
p110d is required to orient the apical-basal axis and lumen
formation through both focal adhesions and basal membrane
organization.
Results
p110d activity controls apico-basal axis and lumen formation.
All class I PI3K isoforms generate PtdIns(3,4,5)P3 and thus the
kinase activity of individual PI3K isoforms cannot be readily
distinguished in cells by detection of their lipid product or by
using broad-spectrum PI3K inhibitors such as wortmannin and
LY294002.
We therefore tested ATP-competitive isoform-selective inhibi-
tors of PI3K (ref. 24) on apico-basal polarity of MDCK grown in
three-dimensional (3D) as a model system. These include PI-103,
a multi-targeted inhibitor for p110a/b/d/g, which inhibits p110a
most efﬁciently but also targets p110b at 10 to 30-fold higher
concentrations, and the isoform-selective inhibitors AS-605240,
TGX115 and IC87114 that target p110g, p110b/p110d and p110d,
respectively. The speciﬁcity proﬁle of these compounds was
previously determined by measuring IC50 values in vitro against
puriﬁed PI3K family members24. We also used CAL-101, now
called Idelalisib, a derivative of IC87114 with increased potency,
which is in clinical trials for B-cell malignancies25,26.
To test these pharmacological inhibitors on apico-basal
polarity, single MDCK cells were grown on matrigel to form
cysts. Twenty-four hours after plating, cells were treated or not
with the different PI3K inhibitors for 72 h, followed by confocal
microscopy analysis. In non-treated control cysts, b-catenin
staining revealed a monolayer of polarized cells surrounding an
open central lumen as visualized by the apical marker
podocalyxin (PCX; Fig. 1a, left panel). Following the localization
of PCX enabled the investigation of the impact of PI3K inhibition
on the establishment of epithelial apico-basal polarity. The four
major phenotypes (multi-lumens, no lumen, small and inverted
polarized cysts) obtained following treatments with the different
inhibitors are represented in Fig. 1a. The percentages of each
phenotype depending on the concentrations of inhibitors were
gathered in the Supplementary Fig. 1 and presented as pie charts
in Fig. 1b. Cysts treated with PI-103 showed a dose-dependent
change in lumen formation and cyst growth. At a concentration
of 10 mM, 62.33% of the cysts presented no lumen and were very
small in size. AS-605240, a selective p110g inhibitor, had effects
similar as PI-103 even though the number of small cysts was
reduced (36.68% at 10 mM). Treatment of cysts with TGX115 led
to the formation of cysts with multi-lumens and no lumen.
Moreover, a small proportion (6.52% at 10 mM) of cysts with
inverted polarity was seen, detected via the persistence of PCX
localized at the cyst periphery. Treatment with the p110d
inhibitor IC87114 increased the number of cysts with inverted
polarity signiﬁcantly in a dose-dependent manner, from
3.14 to 34.31% at 0.1 mM and 10 mM of IC87114, respectively.
These data were conﬁrmed using CAL-101 (Idelalisib), another
speciﬁc inhibitor of the p110d. Together these data indicated
that all the isoforms of class I PI3K participate in the establish-
ment of epithelial cell polarity. However, only the inhibition
of p110d elicited an inversion of apico-basal polarity in a
population of cysts, which is suggestive of a speciﬁc role of the
latter isoform of PI3K in the establishment of the apico-basal
polarity axis.
To validate this proposition, we further investigated the effect
of IC87114 at 10 mM on the different stages of lumen formation
(Fig. 2a) as described in a previous report27. As presented in the
top panels of Fig. 2a when plating individual MDCK cells in 3D
culture at the early stage of cyst formation, PCX initially localized
at the ECM-contacting surface in early aggregates with b-catenin
accumulating at cell–cell junctions. As cysts develop polarity,
PCX is displaced at the centre of the cell–cell contact at a site
called the apical membrane initiation site (AMIS). The lumen
then starts to develop at a site termed the ‘pre-apical patch’ (PAP)
at 48 h of culture and becomes visible at 72 h and then continues
to develop as seen at 96 h of culture (Fig. 2a). In striking contrast
to control cysts, on treatment with IC87114, PCX was found to
remain at the ECM surface until 96 h, while the cells continued to
proliferate and maintain cell-to-cell contacts as shown by b-
catenin and nuclei staining (Fig. 2a). We also analysed the
localization of the tight junction protein Zonula occludens
protein 1 (ZO-1) at the early stages of lumen formation. As
observed for PCX, treatment with IC87114 resulted in the
inappropriate accumulation of ZO-1 at the cell periphery, while
tight junctions formed at the apico-lateral boundary in control
cysts (Fig. 2b). Statistical analysis of the impact of p110d
inhibition on the observed lumen morphologies indicated a
signiﬁcant decrease in the proportion of cysts with a central
lumen (or lumen precursor) regardless of days in culture (Fig. 2c).
These data strongly suggest that the enzymatic activity of p110d is
required to orient the apico-basal polarity axis and to drive the
formation of AMIS, which is necessary for lumen formation.
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p110d is expressed at the basolateral membrane. The results
described above indicated a crucial function of p110d in estab-
lishment of cell polarity. p110d is known to be mainly expressed
in cells of the haematopoietic lineage, and although several stu-
dies have reported expression in epithelial cells28,29, its possible
role in epithelial morphogenesis has not been determined. Thus,
we decided to further characterize the p110d protein expression
and localization in MDCK cells.
First, we examined by immunoblot the expression of p110d in
MDCK cells using as a positive control a lysate from HeLa cells, a
non-leukocyte cell that is known to express high levels of p110d
(refs 13,30). A 110-kDa protein was detected in both cell lines;
however, the intensity of the signal was very weak in MDCK cells
(Supplementary Fig. 2a; the speciﬁc band is marked with an
arrow), which is in line with the quantitative reverse
transcription–PCR (qRT–PCR) analysis for p110d mRNA
abundance in these cells (Supplementary Fig. 2b). The ampliﬁed
qRT–PCR product from MDCK cells presented a product of the
same size as the product isolated from HeLa cells (Supplementary
Fig. 2c) and with similarity to the p110d canine sequence, as
shown in (Supplementary Fig. 2d). Then we examined the
presence of the different class I PI3K isoforms in MDCK cells
using qRT–PCR. Data presented in Supplementary Fig. 2e
indicated that the p110b isoform was the most highly expressed.
Together these results indicated the presence of the p110d in
MDCK cells.
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Figure 1 | p110d activity is required for polarity in MDCK cysts. (a) MDCK cells, plated on Matrigel to form cysts, were treated 24 h after plating with
different p110 inhibitors: PI-103 (inhibitor of p110a, b, g and d), AS-605240 (inhibitor of p110g), TGX115 (inhibitor of p110b and d), IC87114 and CAL-101
(inhibitors of p110d). Inhibitors were used at different concentrations (0–10 mM). Cysts were grown for another 72 h with a daily change of the medium
containing inhibitor. Cysts presented different phenotypes (Normal lumen, multi-lumen, no lumen, small cysts with no lumen and inverted polarity). These
phenotypes were identiﬁed by staining b-catenin in green, PCX in red and Hoechst (blue) as indicated in the pictures. A confocal section through the
middle of cyst is shown. Scale bar, 10mm. (b) The table shows a schematic representation of phenotype at different concentrations. Colour for each
phenotype in pie is corresponding to the color below pictures in a. (c) The same representation as in b for cells not treated.
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Next we validated the antibody and the subcellular localization
of p110d in polarized MDCK cells through transfection of the
cells with different p110d constructs. First, MDCK cells were
transfected using an untagged p110d cDNA (UT-p110d) and the
efﬁciency of the transfection was validated by immunoblot
analysis (Fig. 3a) using a p110d-speciﬁc antibody (sc: anti-p110d).
In transfected cells, we observed an intense signal at 110 kDa
corresponding to the size of the signal observed in the lysate of
HeLa cells, used here as a positive control. In parallel, we assessed
the subcellular localization of the exogenous p110d protein in
transfected cells plated to form cysts in matrigel culture (Fig. 3b).
Staining of the aforementioned cysts with one of the commer-
cially available p110d-speciﬁc antibodies (sc: Anti-p110d)
revealed a basolateral signal in both control and the untagged
p110d cDNA transfected cells, as expected. As anticipated, based
on the results of the immunoblotting analysis using this antibody
(Fig. 3a), the signal was weaker in control cells when compared
with the transfected cells (Supplementary Fig. 3). Similar results
were obtained using a different commercial antibody raised
against p110d (ab: anti-p110 d; Supplementary Fig. 3; Fig. 3b). On
the basis of these immunolocalization data, it was determined
that the antibody from Abcam was more appropriate for
downstream immunoﬂuoresence studies because of the higher
signal intensity achieved using this reagent in these cells. Next we
used Myc-tagged p110d cDNAs expressed from two different
expression vectors (Myc1-p110d, Myc2-p110d, see methods).
Immunoblot analysis revealed that the two exogenous proteins
were detected with both p110d- and Myc-speciﬁc antibodies as
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Figure 2 | p110d activity is required for lumen initiation in MDCK cysts. (a) Time course analysis of polarity and lumen formation in MDCK cells, treated
or not with 10mM of IC87114 and plated on Matrigel to form cysts, ﬁxed and stained after 24, 48, 72 and 96 h of culture, corresponding to different
stages of lumen formation: PAP, pre-apical patch and open lumen. Cells were stained for b-catenin (green) and PCX (red) and a single confocal
section through the middle of cyst is shown. Scale bar, 10mm. (b) Cells were grown as in a and analysed after 24, 48 and 72 h of culture and stained for
b-catenin (red) and ZO-1 (green) and a single confocal section through the middle of cyst is shown. Scale bar, 10mm. (c) Percentage of MDCK cysts
with AMIS, PAP or open lumen from three independent experiments were presented in histograms. Values are expressed as mean±s.e.m. *Po0.05,
***Po0.0001 (Student’s t-test).
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shown in Fig. 3c and Supplementary Fig. 4a, respectively, for
Myc2-p110d and Myc1-p110d. Furthermore, we used the Myc tag
and p110d antibodies to analyze by immunoﬂuorescence the cysts
from cells transfected or not (Ctrl) with Myc2-p110d cDNA. The
two antibodies speciﬁcally labelled the Myc-tagged-p110d protein
at the basolateral membrane (Fig. 3d). The signal of p110d
expression in the Myc2-p110d expressing cysts was measured by
ImageJ analysis and compared to endogenous p110d signal
(Fig. 3e). These data conﬁrmed a signiﬁcantly increased signal
intensity of p110d on enforced expression of exogenous protein
(Fig. 3e). 3D reconstructions for Ctrl and Myc2-p110d cysts were
presented in Fig. 3d. Basolateral localization was also observed for
Myc1-tagged p110d (Supplementary Fig. 4b). Thus, together
these data indicated that p110d-speciﬁc antibodies detected both
endogenous and the exogenous proteins. We concluded that the
localization of exogenous p110d is similar to the subcellular
distribution observed for the endogenous protein at the
basolateral membrane. Co-staining of p110d in Myc2-p110d-
expressing cysts with b-catenin indicated that the distribution
pattern of p110d is different from that of b-catenin, which is
mainly present in the lateral domain (Supplementary Fig. 4c).
p110d membrane localization depends on its enzymatic activity.
In subsequent experiments, we analysed p110d protein cellular
localization during cystogenesis (Fig. 4) and we conﬁrmed its
basolateral staining at the different stages of cyst formation
(Fig. 4a). Treatment with IC87114 induced the displacement of
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Figure 3 | p110d localization at the basolateral membrane of MDCK cysts. (a) Immunoblot analysis of p110d in MDCK transfected or not with 1mg of
untagged p110d cDNAs (UT-p110d), using p110d-speciﬁc antibody (sc7176). HeLa cells are positive control for p110d and actin was used as a loading
control. (b) MDCK cells in a were grown in Matrigel to form cysts and then stained for p110d (green) using p110d-speciﬁc antibody (ab32401), actin (red)
and Hoechst (blue) as indicated in the pictures. Single confocal section through the middle of cyst is shown. Scale bar, 10mm. (c) Immunoblot analysis of
MDCK transfected or not with different amounts (0.5, 1 and 2 mg) of Myc-tagged-p110d cDNA (Myc 2-p110d) and revealed with p110d (sc7176) and
myc tag antibodies. Actin was used as a loading control. (d) Cells in c were grown in Matrigel to form cysts and then stained for p110d using p110d-speciﬁc
antibody (ab32401) or Myc (green), actin (red) and Hoechst (blue) as indicated in the pictures. Single confocal section through the middle of a
cyst is shown. Scale bar, 10mm. A 3D reconstruction from all xz sections is presented in the bottom panel. (e) Quantiﬁcation of p110d intensity by ImageJ
from 20 cysts from three independent experiments, values are expressed as mean±s.e.m., ***Po0.0001 (Student’s t-test).
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p110d from the membrane at the ECM contact site to the cyto-
plasm as demonstrated by analysis of the p110d staining signal
using imageJ (see Methods; Fig. 4b,c). We next sough to evaluate
the effect of IC87114 on the exogenous Myc-tagged-p110d
membrane localization (Fig. 4d). Similar to the endogenous
protein, IC87114 treatment signiﬁcantly decreased the membrane
signal of Myc with a concomitant shift into the cytoplasmic area
(Fig. 4e).
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Figure 4 | p110d localization at the basolateral membrane of MDCK cysts depends on its activity. (a) Time course analysis of p110d in MDCK cells
grown on Matrigel to form cysts and treated or not with IC87114 at 10mM. Cysts were ﬁxed and stained after 24, 48 and 72 h of culture. Immunostaining
was performed for p110d (green) using p110d-speciﬁc antibody (ab32401), PCX (red) and Hoechst (blue) as indicated on the pictures. Single confocal
section through the middle of cyst is shown. Scale bar, 10mm. A higher magniﬁcation of the data from 72 h of culture is presented in the right column.
(b) The distribution of p110d signal was analysed by ImageJ software in an individual cell from a cyst. A circle was deﬁned at the periphery of each cell and
the plugin produces a proﬁle plot of normalized integrated intensities around concentric circles as a function of distance from a point in the image,
considered here as the centre of the cell. The circle was divided in three bands (1, 2, 3) with equal radius. (c) The total intensity in each band was calculated
from 20 cells and is represented as a histogram. values are expressed as mean±s.e.m. ***Po0.0001 (Student’s t-test). (d) MDCK cells transfected with
1mg of Myc 2-p110d cDNA were treated or not with 10mM of IC87114. MDCK cells were also transfected with 1 mg of Myc-p110 kinase-dead (KD) cDNA.
Immunostaining was performed for Myc (green), actin (red) and Hoechst (blue) as indicated on the pictures. Single confocal section through the
middle of the cyst is shown. A higher magniﬁcation of the data is presented in the right column. Scale bar, 10mm. (e) The distribution of Myc signal was
analysed by ImageJ software in an individual cell from a cyst as in b, and total intensity in each band calculated from 20 cells was represented as
histogram. values are expressed as mean±s.e.m. **Po0.001 (Student’s t-test).
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Finally, we used the kinase-dead mutant (R894P) of p110d
(Myc-p110d kinase-dead) to validate the effects of the pharma-
cological inhibitors. MDCK cells were transfected with the
corresponding cDNA and grown on matrigel to form cysts.
Myc-p110d kinase-dead protein, revealed with Myc antibody, was
signiﬁcantly localized in the cytoplasm (Fig. 4d,e) demonstrating
that membrane localization of p110d is dependent on its
enzymatic activity. Of interest, these cells expressing the mutant
protein formed inverted polarized cyst (about 29%) with actin
present at the cell periphery, while in control cysts actin marks
the central lumen (Fig. 4d). These data are analogous to those
obtained with treatment of cells using CAL-101 or IC87114
(Fig. 1) and conﬁrmed the requirement of active p110d to orient
polarity and allow lumen formation.
PtdIns(3,4,5)P3, monitored using a speciﬁc antibody, was
mainly observed at the basolateral membrane, in line with
previous studies using the PH domain of Akt as a PtdIns(3,4,5)P3
probe21. In accordance with the observations made for the p110d
protein localization in cysts (Supplementary Fig. 4d,e), inhibition
of its activity signiﬁcantly reduced the observed PtdIns(3,4,5)P3
membrane localization with a concomitant shift of the immuno-
reactive population to a cytoplasmic pool. Taken together, these
results strongly suggest that localization of the majority of
PtdIns(3,4,5)P3 at the basal membrane in MDCK cysts is
dependent on p110d kinase activity.
p110d controls Rac1 activation and BM assembly. Cell contacts
with the ECM trigger numerous signalling events that provide the
initial cue to deﬁne the polarity axis. The laminins are major and
important biologically active components of the basement
membrane (BM), a thin layer of ECM underlying the epithelial
cells. Several publications have now reported the crucial role of
laminins in orientation of apico-basal polarity axis through the
activation of Rac1 (refs 31–34). PI3Ks are important regulators of
Rac1 (refs 21,35) and its implication in Rac1-mediated regulation
of lumen formation has been evoked36.
Therefore, and according to the observed effects of p110d
inhibition on orientation of the apico-basal axis, we evaluated
Rac1 activation and, importantly, it is increased with lumen
formation. Rac1 activation was signiﬁcantly reduced by treatment
of cysts with IC87114 (Supplementary Fig. 5), suggesting that
p110d activity could affect activation of Rac1. Next we examined
the possible role of p110d activity on laminin assembly. As
presented in Fig. 5a, (the xz section was presented below each
picture and the 3D reconstruction was shown on the right part of
the panel), laminin was visible at the cyst periphery and formed a
prominent structure covering the control cysts that disappeared
on treatment of cells with IC87114, while laminin was still present
in the culture gel. Under such conditions, PCX is externalized
(red staining) and further conﬁrms the inverted polarization of
the IC87114 treated cysts. The treatment of cysts with CAL-101
led to data similar to those obtained using IC87114. Then, we
analysed laminin staining in cysts from MDCK cells expressing
the Myc-p110d kinase-dead mutant (Fig. 5b) and no laminin was
found surrounding these cysts suggesting that the recruitment of
laminin at the site of cell contact with the ECM required p110d
activity. Along with laminins, type IV Collagen is a key ECM
protein, essential for maintaining the structural integrity of BM37.
Accordingly, we also analysed type IV Collagen assembly in the
system. Of interest, the treatment of cysts with IC87114 or CAL-
101 removed the layer of type IV Collagen underlying the cysts as
observed in controls (Fig. 5c). Taken together, these results
strongly suggested that p110d is necessary for the assembly of the
BM at the cell surface and that it probably fulﬁlls this role by
regulation of a signalling pathway that involved Rac 1 activation.
ECM regulates p110d expression. To further characterize the
interplay between PI3K and ECM, ﬁrst MDCK cells were trans-
fected with Myc-tagged p110d cDNA (Myc2-p110d) and plated
on matrigel to form cysts, then laminin and type IV Collagen
distributions were assessed at the different stages of cystogenesis.
As presented in Fig. 6a, laminin was visible at the cyst periphery
and the signal signiﬁcantly increased from the AMIS stage (24 h
of culture) to large lumen at 96 h of culture (Fig. 6a,b). The
laminin layer surrounding the cysts became thicker whatever the
stage of polarization was due to the enforced expression of Myc 2-
p110d (Fig. 6a,b). These data are consistent with those obtained
from the analysis type IV Collagen distribution in these cysts
(Fig. 6c,d).
Next we examined the possible role of ECM in regulating the
expression of p110d. To this end, multiwell plates were either
coated or not with various ECM components, including: type I
collagen, laminin, ﬁbronectin or poly-D-Lysine. MDCK cells were
plated for 24 h on the different ECM-coated supports and analysis
for the impact of different ECM components on p110d expression
was performed by immunoblotting. P110d expression is increased
in response to cell interactions with all ECM substrates analysed
in comparison with expression levels of p110d expression
detected on an untreated support (Ctrl; Fig. 6e). Similar data
were obtained using RT–PCR analysis of p110d gene expression
under these treatments (Fig. 6f). Moreover, we demonstrated that
p110d mRNA level increased signiﬁcantly in cells grown on
matrigel (Fig. 6g). Although there were no statistically signiﬁcant
differences between the effects of the different ECM proteins
tested in our experimental conditions at the p110d protein
level, collectively these data are supportive of a role for ECM
components in positively regulating p110d expression.
Depletion of p110d inverts polarity and impairs BM assembly.
To validate the speciﬁcity of the observed effects with the phar-
macological inhibitors of p110d, we used three different short
interfering RNAs (siRNAs; si1, si2 and si3) that isoform speciﬁ-
cally reduced the abundance of the p110d transcript, since there
was no effect of these siRNAs on the mRNA levels of p110a, b
and g (Fig. 7a). The mechanism by which PtdIns(3,4,5)P3 reg-
ulates cellular signalling was ﬁrst revealed for Akt38. Thus, we
analysed the effects of p110d expression on the phosphorylation
status of Akt. No signiﬁcant change in pAkt was observed after
the depletion of p110d using each of the three different siRNAs
and on the stimulation of cells with epidermal growth factor
(Supplementary Fig. 6). Consistent results were obtained on the
overexpression of Myc-tagged p110d, strongly suggesting that
p110d is not a key signalling molecule for Akt phosphorylation
(Supplementary Fig. 6). Similar data were previously observed in
endothelial cells39.
Next MDCK cells treated or not with siRNA (si3) were grown
on matrigel to form cysts. The speciﬁcity of si3 was further
veriﬁed by immunoblot (Fig. 7b). In control cysts, p110d was
found at the basal membrane (as described in Fig. 3) and the
signal was profoundly reduced in cysts from siRNA-treated cells
conﬁrming a speciﬁc signal for the antibody (Fig. 7c). Consistent
with our inhibitors studies, PCX was located at the cyst periphery
in siRNA-treated cysts as evidenced by the 3D reconstruction of
the confocal data (Fig. 7c right panels). The tight junctions
marker (ZO-1), normally present at the tip of b-catenin positive
cell–cell contacts in control cysts was now found at the basal
region of cysts formed from siRNA-treated cells (Supplementary
Fig. 7). Analysis of confocal data indicated that 35% (±2.76%) of
the total cysts presented an inversion of polarity, with PCX
present at the external surface (Fig. 7d). These data are consistent
with those obtained on treatment of cells with IC87114 or
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CAL-101 (Supplementary Fig. 1). The percentage of cysts with
inverted polarity observed in our study is also consistent with the
outcomes (30–50%) recently published in different studies34,40.
Moreover, in the p110d depleted and inverted polarized cysts, no
laminin (Fig. 7e), or type IV collagen (Fig. 7f), was detected at the
cyst periphery. Taken together, these data conﬁrmed that p110d is
required for the orientation of the apico-basal axis, lumen
formation, laminin and type IV Collagen assembly through an
inside-out signal.
p110d is required for focal adhesion stability. The spatial cues
from cell adhesion to the ECM are mediated primarily through
integrins, an adhesion molecule superfamily of heterodimeric
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or CAL-101) were grown on matrigel for 4 days to form cysts and then ﬁxed and stained with laminin (green), PCX (red) and Hoechst (blue) as indicated on
the pictures. A confocal section through the middle of the cyst is shown and the xz section is presented below each panel. Scale bar, 10mm. 3D
reconstruction from all xz sections is presented in the right column. (b) MDCK cells transfected or not with 1 mg of Myc-p110d KD were grown on matrigel
for 4 days to form cysts and then ﬁxed and stained with laminin (green), Myc (purple) and Hoechst (blue) as indicated on the pictures. A confocal
section through the middle of cyst is shown and xz section is presented below each panel. Scale bar, 10mm. 3D reconstruction from all xz sections is
presented in the right column. (c) Cells treated as in a stained with type IV collagen (green), PCX (red) and Hoechst (blue) as indicated in the pictures.
A confocal section through the middle of the cyst is shown and the xz section is presented below each panel. Scale bar, 10mm. 3D reconstruction from
all xz sections is presented in the right column.
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transmembrane proteins composed of a and b subunits with
variable afﬁnities towards the different ECM proteins and speciﬁc
roles in ECM assembly and remodelling41,42. b1 integrins are
widely expressed in epithelial cells, and studies using both
function-blocking antibodies and genetic deletion approaches
have revealed that they control BM deposition, control BM
AMIS
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Ctrl
AMIS
AMIS
Open lumen
Open lumen
PAP
PAP
Ctrl
Myc 2-p110δ
Myc 2-p110δ
p110δ
p110δp110δ
AMIS
PAP
PAP
Actin
Ctr
l
Ctr
l
Ctr
l
Ma
trig
el
Fib
ron
ec
tin
Fib
ron
ec
tin
Po
ly-
D-
lys
in
Po
ly-
D-
lys
in
Typ
e I
 co
llag
en
Typ
e I
 co
llag
en
La
mi
nin
La
mi
nin
Open
lumen
Open
lumen
0 10 20
Laminin
Signal intensity per cell
Laminin/Actin
Type IV collagen/Actin
Type IV collagen
Signal intensity per cell
30
0 10 20 30
MW
(KDa)
100
50
375
4
D
en
si
to
m
et
ry
3
2
1
0
0
0.5
1.5
2.5
m
R
N
A 
ex
pr
es
sio
n
m
R
N
A 
ex
pr
es
sio
n
1
2
0
0.5
1.5
2.5
**
**
**
*
*
1
2
Ctrl
Ctrl
Myc 2-
p110δ
Myc 2-
p110δ
Ctrl
Ctrl
Myc 2-
p110δ
Myc 2-
p110δ
Figure 6 | ECM regulates p110d expression. (a) MDCK cells transfected or not with 1 mg of Myc 2-p110d were grown on matrigel and ﬁxed after 24 h for
AMIS, after 48 h for PAP and after 72 h for open lumen. Cells were stained with laminin (green), actin (red) and Hoechst (blue) as indicated in the pictures.
A confocal section through the middle of cyst is shown. Scale bar, 10mm. 3D reconstruction from all xz sections is presented in a grey background. Laminin
signal intensity of individual cell is analysed with ImageJ software for 30 cells and represented as histogram in b. Values are expressed as mean±s.e.m.
***Po0.0001 (Student’s t-test). (c,d) Same as a and b, respectively, for type IV collagen staining (green) and signal intensity. (e) MDCK cells grown for
24 h on ﬁbronectin, poly-D-lysine, collagen or laminin coated coverglasses and non coated coverglass (Ctrl) were analysed by immunoblot for p110d
expression using p110d-speciﬁc antibody (sc7176). Actin was used as a loading control. Relative densitometry analysis of p110d from three different
experiments was analysed and presented in histograms below. Values are expressed as mean±s.e.m. (f) Total RNA from cells in e were analysed by
qRT–PCR for p110d expression and normalized to GAPDH. Values from three independent experiments are expressed as mean±s.e.m. *Po0.05,
**Po0.001 (Student’s t-test). (g) Total RNA from cells grown or not on Matrigel for 4 days were analysed by qRT–PCR for p110d expression and normalized
to GAPDH (see Methods). Values from three independent experiments are expressed as mean±s.e.m. *Po0.05 (Student’s t-test).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6937 ARTICLE
NATURE COMMUNICATIONS | 6:5937 | DOI: 10.1038/ncomms6937 | www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
assembly and have a central role in establishing apico-basal
polarity33,43. The b1 integrin is involved in different
combinations with many alpha subunits including a2 and a5
showing a preference for collagen and ﬁbronectin receptors,
respectively. The a2b1 integrin combinations are also able to
interact with laminin41. Therefore, we analysed the b1, a2
and a5 integrins in p110d-disrupted cells. In control cysts, the
staining of b1 integrin, a2 integrin and a5 integrin were
mainly detected at the basolateral membrane of polarized
cysts. Knockdown of p110d expression using siRNA as well as
treatment of cells using CAL-101 dramatically reduced
the staining for the different integrins and particularly of b1
integrin, where the signal was largely abolished (Supplementary
Fig. 8).
The binding of integrins to ligand initiates the connection
between the cytoskeleton and the ECM and contributes to the
recruitment of additional cytoskeletal and signalling proteins such
as talin, vinculin and paxillin that create focal adhesions and
regulate cell shape and polarity1,44. Thus, to further characterize
the effect of p110d on ECM signalling and focal adhesions, we
examined both paxillin and vinculin expression and organization.
In control cysts, paxillin was organized at the basolateral
membrane adjacent to laminin, while the protein became more
cytoplasmic and diffuse on treatment of cysts with IC87114
(Fig. 8a,b). Similar observations were made for vinculin
(Fig. 8c,d), indicating that p110d activity regulates paxillin and
vinculin subcellular localization and partly co-localized with them
(Supplementary Fig. 9).
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We next investigated focal adhesions by growing cells on glass
to better visualize these structures. Under such conditions,
vinculin localized at the ends of actin stress ﬁbres, whereas in
cells treated with p110d siRNA vinculin formed smaller and
punctuate foci dispersed in the cytoplasm (Fig. 8e). A prominent
effect of p110d siRNA was also observed on paxillin distribution
(Fig. 8f). The level of tyrosine phosphorylation of paxillin is
known to positively correlate to dynamism of adhesion sites45.
Decreased paxillin phosphorylation reduces the turnover of focal
contacts and their stabilization, which is required for cell
differentiation and polarization. Immunoblotting revealed a
decrease in the phosphorylation of paxillin on tyrosine-118
(pPaxillin) on p110d overexpression (Fig. 8g), suggesting that
p110d could promote the stabilization of focal contacts at the
basal membrane.
p110d co-localizes with b-DG and regulates its localization.
Although the most intensively studied receptors for ECM com-
pounds are integrins, dystroglycan (DG) is another high-afﬁnity
laminin receptor, originally identiﬁed in studies on muscular
dystrophy46,47. DG is a heterodimeric glycoprotein that consists
of a transmembrane b-subunit and a non-covalently associated,
extracellular a-subunit. The cytoplasmic domain is linked to the
actin cytoskeleton, whereas the extracellular domain is implicated
in laminin assembly and subsequently shown to play important
roles in the cell–ECM interactions, BM assembly, cell polarity and
morphogenesis48–51.
Consistent with the absence of ECM at the periphery of
inverted polarized cysts, we hypothesized that DG could also be
regulated by p110d. In control cysts, b-dystroglycan (b-DG) was
clearly visible at the basal membrane at the ECM contacts and
some co-localization with p110d was observed, which increased
on p110d overexpression (Fig. 9a). In contrast, siRNA-mediated
p110d knockdown strongly reduced b-DG membrane localization
with a drastic reduction of the co-localization signal (Fig. 9a).
Treatment of cysts with IC87114 yielded similar results to those
observed using the isoform speciﬁc siRNA strategy (Fig. 9b). We
further reinforced these observations by using CAL-101 to inhibit
p110d enzymatic activity. As shown in 2D and 3D reconstruc-
tions, the b-DG signal that outlined cell periphery in untreated
cysts disappeared and instead accumulated at the bottom of the
cysts (Fig. 9c). Collectively, these data emphasize the functional
contribution of p110d in b-DG localization at the basolateral
membrane. Next we investigated the existence of a feedback
control loop of b-DG on p110d expression and localization. In
concert with our predictions, siRNA-mediated knockdown of b-
DG led to cysts exhibiting inversion of polarity and to the absence
of laminin accumulation at the cyst periphery (Fig. 9d,e). Under
these experimental conditions, p110d was found mostly in the
cytoplasm (Fig. 9f). In conclusion, these data demonstrate that
p110d localization at the basal membrane is also regulated by an
outside-in signal from the ECM via b-DG that drives the
orientation of polarity axis.
Discussion
PI3Ks transmit signals from transmembrane receptors such as
receptor tyrosine kinases and G-protein-coupled receptors to
control a diverse array of signalling pathways through spatio-
temporal recruitment of multiple effectors containing PI-speciﬁc
binding domains. Thus, they regulate key cellular processes
including, cell migration, proliferation, differentiation and
survival and as such are targeted for intensive research across
the ﬁelds of inﬂammation, immunity, cancer and metabolic
diseases12,38,52. PtdIns(3,4,5)P3, the major product of class I PI3K,
plays a crucial role in the generation of epithelial polarity16. In
line with these previous publications, our results indicate that all
of the isoforms of class IA PI3Ks participate in MDCK cyst
morphogenesis and the development of epithelial polarity (Fig. 1).
The different phenotypes observed using speciﬁc isoform
inhibitors (Fig. 1) suggested that each of the isoforms has a
particular function at a different step of the intricate polarity
programme. Unexpectedly, only inhibition of the isoform delta,
the least abundantly expressed isoform in MDCK cells, affects the
initiation of lumen formation and orientation of the apico-basal
polarity axis.
Through the use of mice with inactivated p110d and also
selective inhibitors, such as the IC87114 and CAL-101
compounds, the p110d isoform of PI3K has been extensively
studied in leukocytes and is designated as a potential therapeutic
target in immunity, inﬂammation and haematological malignan-
cies53–57. Nevertheless, mice lacking PI3Kd have thus far only
been studied under basal conditions. Yet, mice lacking PI3Kd
have thickened intestinal mucosa with hyperplasic glands and
mixed inﬂammatory inﬁltration of the lamina propria54. Even
though these effects were attributed to the neutrophilic
inﬂammation, one could not exclude an effect on the epithelial
cells, which composed the mucosa. Thus, further in vivo studies
were required to determine the polarity defects associated with
PI3Kd knockdown in vivo. The preponderance of studies of
p110d function in haematological systems has contributed to the
dogma of a restricted role of p110d in cells of haematopoietic
lineage. Of interest, the development of PI3K isoform-selective
inhibitors12,58–61 and the determination of its crystal structure62
has advanced the emerging studies of p110d function in non-
haematopoietic cells. Still, most of these studies are related to
p110d expression in cancer where p110d has been shown to be
the predominant isoform expressed in different human solid
tumour cells including; glioblastoma, neuroblastoma, prostate
carcinoma and breast cancer63. A recent report indicated a
somatic mutation in PI3Kd that is associated with recurrent
infections and airway damage64. Thus, a better understanding of
the regulation and function of p110d in non-haematopoietic cells
and their connections to oncogenesis is both warranted and
timely.
In the present study, we provided important insights into the
fundamental role of p110d in the establishment of apico-basal
polarity axis and lumen formation in MDCK cells. It is generally
accepted that the acquisition of epithelial polarity depends on
signalling generated through cell interactions with neighbouring
cells and with the surrounding ECM4,5,31. Integrins are critical
components of this signalling pathway and are known
modulators of PI3K and PtdIns(3,4,5)P3 levels33,65,66. Integrin-
mediated PI3K activation induces Rac1 activation and thereby
organizes the actin cytoskeleton and recruitment of adaptor
proteins within adhesion complexes (that contain a large set of
proteins, including paxillin and vinculin67). Our data revealed a
role for p110d in the establishment of the apico-basal polarity axis
acting via outside-in signalling cascade that is triggered by cell
adhesion to the ECM where it acts to establish apico-basal
polarity axis and lumen formation that are crucial to epithelial
morphogenesis. Of note, previous studies have reported the
contribution of other isoforms of PI3K, including p110a and
p110b, in the control of integrin signalling66,68 and Rho
GTPases69. Thus, the contributions of the other PI3K isoforms
in epithelial organization were not excluded.
We also demonstrated that the inhibition of p110d activity or
knockdown of its expression affected laminin and type IV
collagen assembly at the cyst periphery. Moreover, these
treatments profoundly reduced the integrin expression and
impaired both paxillin and vinculin focal distribution, where
instead these proteins were found diffuse in the cytoplasm
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(Fig. 8). Furthermore, we showed that different ECM proteins
positively regulated p110d expression (Fig. 6e,f). Together these
data also demonstrated a role for p110d in inside-out signalling to
control basal membrane organization. However, further investi-
gations are necessary to establish the precise inﬂuence of the type
of ECM component, the concentration and the stiffness of the
ECM on p110d expression and on the cell polarization process in
general.
Using a speciﬁc antibody, we demonstrated the presence of
PtdIns(3,4,5)P3 at the basolateral membrane of polarized cysts as
previously reported21. Interestingly, the treatment of cysts with
IC87114 strongly reduced PtdIns(3,4,5)P3 accumulation at the
membrane. It is noteworthy that the intensity of the staining for
PtdIns(3,4,5)P3 in the inhibitor-treated cells was not impacted,
which indicates that p110d is not the only enzyme responsible for
PtdIns(3,4,5)P3 production in our system. However, the
displacement of PtdIns(3,4,5)P3 from the basal membrane on
treatment with IC87114 suggested that p110d is the PI3K isoform
activated at the site of ECM contact during initiation of the
epithelial cell polarization process. These ﬁndings are in
concordance with our previous description of PtdIns(3,4,5)P3 as
a compass for cell polarization and as a regulator of basolateral
membrane formation21.
PI3K is a known effector of small family of GTPases including
Rac1 and the contribution of PI3K downstream of the laminin
signal in the regulation of cell polarity has been reported36.
However, it must be noted that the majority of the previous
studies were performed using the broad-spectrum inhibitors of
class I PI3K, including LY294002 or wortmannin, and as such
they do not enable the identiﬁcation of the speciﬁc PI3K isoform
involved. Here we provide the ﬁrst evidence that the p110d
isoform of PI3K regulates Rac1 activation in the context of apico-
basal polarization in epithelia (Supplementary Fig. 5).
DG is another receptor for laminin that plays critical roles in
BM organization and epithelial polarity through the assembly of
extracellular laminin47,48,51. However, the underlying
mechanisms remain poorly understood. This study revealed
that p110d regulated the maintenance of b-DG at the basal
membrane and reciprocally b-DG controlled membrane
localization of both p110d and its lipid product PtdIns(3,4,5)P3.
DG regulates actin organization and participates in Rac1
activation70, suggesting that p110d could act at the crossroads
between integrin and DG mediated ECM signalling to drive the
cytoskeleton organization and Rac1 activation that are required
for spatial orientation of polarity. However, Rac1 does not seem
to be the only downstream effector of ECM/integrin signalling
during cell polarization40. Understanding the source of this
apparent discordance regarding the role of Rac1 requires further
investigation. There are important changes in ECM composition
according to the cell type and the differentiation stage70.
Moreover, there are different receptors for the myriad ECM
proteins and almost 100 different proteins are present in focal
complexes, including signalling molecules and adaptors. The
apparent complexity of cell–matrix adhesions suggests that only a
subset of proteins participate in different signalling pathways,
clearly indicating that more studies are required to elucidate the
intricacies of the signalling pathways that link cell/ECM contacts
to the polarization process.
PAR-1, a downstream target of the aPKC-PAR-3-PAR-6
complex, regulates the basolateral localization of the DG
complex49. At the early stage of cyst formation, PCX is
localized at the cell periphery in contact with the ECM. It was
shown that membrane trafﬁcking regulated by Rab proteins in
cooperation with Par3–aPKC drives vesicles to the apical surface
to initiate lumen formation27. We have shown here that
inhibition of p110d activity induced maintenance of PCX at the
cell periphery (Figs 1 and 3). Thus, one could speculate that
PI3Kd signalling could play an important role in the targeting of
these apical cargoes through determination of the polarity axis,
although this remains to be determined.
In epithelial cells, dynamic remodelling of the ECM is essential
for the development and normal tissue homeostasis. However,
loss of polarity and uncontrolled ECM remodelling often leads to
ﬁbrotic diseases and cancer. Thus, the analysis of p110d in
carcinoma, in particular those associated with ﬁbrosis, will be of
potential interest for cancer research.
Methods
Inhibitors. TGX115, AS-605240, PI-103 and IC87114 (Symansis) were from Kevan
Shokat (University of California San Francisco, US) and CAL-101 was purchased
from Selleck Chemicals. Stock solutions of the different inhibitors were prepared in
dimethyl sulfoxide and the used concentrations were mentioned in the ﬁgure
legends.
Antibodies. Two primary antibodies were used for p110d, the rabbit anti p110d
from Santa Cruz sc7176 (1:500 dilution is used for immunoblot and 1:50 dilution is
used for immunoﬂuorescence staining in Supplementary Fig. 3) and the anti-PI 3-
Kinase p110d antibody from Abcam ab32401 (1:50 dilution is used for immuno-
ﬂuorescence only). The other antibodies used were: Mouse anti PtdIns(3,4,5)P3
(Echelon Biosciences (Tebu-Bio Z-G345), 1:50), mouse Anti b-distroglycan
(Abcam ab49515, 1:50 for immunoﬂuorescence and 1:1,000 for immunoblot),
rabbit anti type IV collagen (Abcam ab6586, 1:100 for immunoﬂuorescence),
Rabbit anti b-catenin (Santa Cruz sc-7199, 1:100 for immunoﬂuorescence), mouse
anti integrin b1 (Santa Cruz sc-18887, 1:50 for immunoﬂuorescence), mouse anti
paxillin (Cell Signaling 612642, 1:100 for immunoﬂuorescence and 1:1,000 for
immunoblot), rabbit anti phospho paxillin Tyr118 (Cell Signaling 2541, 1:100 for
immunoﬂuorescence and 1:1,000 for immunoblot), rabbit anti Laminin (Sigma
L9393, 1:100), mouse anti Vinculin (Sigma 031M4818, 1:100), goat anti Actin (I-
19) (Santa Cruz sc-1616, 1:2,000), mouse Anti Myc (Sigma M4439 1:100 for
immunoﬂuorescence and 1:1,000 for immunoblot), mouse anti integrin a2 (BD
biosciences V75320, 1:50) and mouse anti integrin a5 (BD biosciences I55220,
1:50). The mouse anti PCX antibody (1:1,000) was from George Ojakian (Uni-
versity of New York Downstate Medical Center), USA. Rat anti ZO-1 antibody
(dilution 1:100) was from Bruce Stevenson (University of Alberta, Edmonton, AB,
Canada). Secondary antibodies used were highly cross-absorbed anti-mouse, anti-
rabbit or anti-goat Alexa Fluor 546 and 488 (Invitrogen, 1:100). Actin was stained
with Alexa Fluor 546 phalloidin (Invitrogen A22283, 1:100) and nuclei with
Hoechst 34580 (Invitrogen H21486, 1:5,000). Secondary horseradish peroxidase
antibodies were anti-goat, anti-rabbit or anti-mouse (Sigma, 1:2,000).
Cells and 3D culture. MDCK (Madin–Darby Canine Kidney) cells (Keith Mostov,
UCSF, San Francisco), were cultured in minimal essential medium containing
Earle’s balanced salt solution supplemented with 5% fetal bovine serum and 1% of
penicillin/streptomycin solution (10,000Uml 1/10,000 mgml 1) at 37 C in 5%
CO2, 95% air. For 3D culture, MDCK cells were trypsinized as 15,000 single
cellsml 1 in 2% Matrigel (BD), 500ml of cells were plated in each well of eight-
well Lab-Tek II chamber slides (Thermo Fisher Scientiﬁc) precovered with Matrigel
and grown for 4 days until cysts with lumen formed. The human HeLa cells (from
ATCC) were cultured in Dulbecco’s modiﬁed Eagle’s Medium containing 4.5 g l 1
glucose supplemented with 10% heat-inactivated fetal bovine serum, 1% non-
essential amino acids and 1% penicillin/streptomycin.
To analyze the effect of the ECM on p110d, MDCK cells were plated for 24 h on
8-well CultureSlides precovered with Fibronectin, poly-D-Lysine, type I Collagen or
Laminin (from BD Biosciences).
SiRNA, plasmids and cell transfection. The speciﬁc p110d duplex RNAi
used were: si1:50-CAACAUCCAGCUAAACAAA[dT][dT]-30 and 50-UUUGU
UUAGCUGGAUGUUG[dT][dT]-30 , si2: 50-GAAUAACAGUGAGAAAUUU
[dT][dT]-30 and 50-AAAUUUCUCACUGUUAUUC[dT][dT]-30, si3: 50-CACUU
UAUGCUGUGAUCGA[dT][dT]-30 and 50-UCGAUCACAGCAUAAAGUG
[dT][dT]-30 .
The speciﬁc b-DG duplex RNAi used were: si1: 50-CCUUCUAUGACCACGA
GGA[dT][dT]-30 and 50-UCCUCGUGGUCAUAGAAGG[dT][dT]-30 , si2: 50-GGC
AUAUUGCCAACAAGAA[dT][dT]-30 and 50-UUCUUGUUGGCAAUAUGCC
[dT][dT]-30 , si3: 50-GUUUAUCUGCACACAGUCA[dT][dT]-30 and 50-UGACU
GUGUGUGCAGAUAAAC[dT][dT]-30 .
Human p110d cDNAs were from Bart Vanhaesebroeck, University College
London, UK (MTA-1004.0-0-Acad-OUT-NB-4214), either pMT-SM-human
p110d-WT-3Myc (Myc 1-p110d), pCDNA3tk-human p110d-WT-3Myc (Myc
2-p110d) or the untagged pMT-SM-human p110d (UT-p110d). For transfection,
MDCK cells seeded at low density (1 104 cells cm 2) were transfected with
100 pmol of speciﬁc siRNA or 1 mg cDNA using jetPRIME (Ozyme) according to
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the manufacturer’s instructions. For 3D culture, 24 h after transfection, cells were
detached with trypsin and plated on Matrigel for 4 days as indicated above.
Immunoﬂuorescent staining. MDCK cells were rinsed with ice cold Dulbecco’s
PBS (DPBS) and ﬁxed with 3.7% paraformaldehyde for 30min. Samples were
permeabilized and saturated with DPBS supplemented with 0.7% ﬁsh gelatin and
0.025% saponin for 30min at 37 C and then incubated with primary antibodies.
After the washes, staining was performed with secondary ﬂuorescent antibodies,
phalloidin and Hoechst. Samples were observed with a Leica TCS SP5 AOBS
tandem 30 confocal microscope. Images were collected as TIF ﬁles and analysed
with PhotoShop.
Immunoblot. Cells were lysed in 1 lysis buffer (20mM Tris–HCl (pH 7.5),
100mM NaCl, 1mM EDTA, and 1% Triton-X-100) containing 1 complete
protease and phosphatase inhibitor cocktail (Roche diagnostics). An aliquot of
quantitated proteins was resolved on SDS-polyacrylamide gel electrophoresis and
then electrotransferred onto polyvinylidene diﬂuoride membrane. After transfer,
the membrane was saturated in DPBS containing 0.1% Tween 20 and 5% milk.
Primary antibodies were added overnight at 4 C. After washes in the presence of
DPBS, appropriate secondary antibodies coupled with peroxidase were added.
Immunoblotting was revealed with chemiluminescent peroxidase substrate
(Chemiluminescent Peroxidase Substrate-3, Sigma-Aldrich) and exposure on
Kodak Biomax Light ﬁlm or with Gbox. Blot scans are presented cropped in ﬁgures
and at least one marker position is presented. Uncropped scans are supplied in
Supplementary Fig. 10.
Rac1 activation assay. Rac1 activation was quantiﬁed using G-LIZA Biochem Kit
(luminescence based) from TEBU-BIO as described by the manufacturer. In brief,
cells lysates as described above for immunoblot (1 mgml 1 for protein con-
centration) were incubated in the afﬁnity wells for 30min at 40 C. Antigen-pre-
senting buffer was added for 2min. Primary and secondary antibodies were
incubated for 45min at room temperature. Intensity was measured by luminometer
at 0.3 s with horseradish peroxidase detection reagent. Cell lyses buffer was used as
blank control (RLU, relative light unit).
Quantitative reverse transcription–PCR. Total RNA was isolated using RNeasy
Mini Kit 50 (Qiagen) and applied to reverse transcription using RevertAid First
Strand cDNA Synthesis Kit (Fermentas). The cDNA was analysed by qPCR using
Quanti Tect SYBR Green PCR Kit (QIAGEN) with 7500 Fast Real-Time PCR
System (Applied Biosystems). Reaction parameters were 50 C for 30min, 95 C for
15min, followed by 45 cycles of 94 C for 15 s, 55 C for 30 s and 72 C for 30 s. The
triplicate mean values were calculated using GAPDH gene transcription as refer-
ence for normalization. The primers used are indicated in Supplementary Table 1.
Image analysis. Images obtained by confocal microscopy were analysed by Icy
software for 3D reconstruction. For co-localization analysis, images were treated by
ImageJ software, the plugin ‘Intensity Correlation Analysis’ was used. Co-locali-
zation index was obtained via Pearson’s correlation coefﬁcient (Rr). The values for
Pearson’s coefﬁcient range from 1 to  1. A value of 1 represents perfect corre-
lation,  1 represents perfect exclusion and zero represents random localization.
For intensity distribution in cells, the plugin ‘Radial proﬁl’ was used. For analysis of
a cyst, a circle was deﬁned at the periphery of each cell and the plugin produces a
proﬁle plot of normalized integrated intensities around concentric circles as a
function of distance from a point in the image, considered here as the centre of the
cell. The concentric circles were assembled in three circle bands with equal radius.
The intensity in each band was calculated from the total integrated intensities
around concentric circles present in the band.
Statistical analyses. All values are expressed as mean±s.e.m. Comparison of
mean values was conducted with unpaired Student’s t-test. Statistical signiﬁcance
was determined at *Po0.05, **Po0.001 and ***Po0.0001.
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